PRIME HD DBM Trademark

Trademark Overview


On Tuesday, April 10, 2018, a trademark application was filed for PRIME HD DBM with the United States Patent and Trademark Office. The USPTO has given the PRIME HD DBM trademark a serial number of 87870713. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 14, 2025. This trademark is owned by Musculoskeletal Transplant Foundation. The PRIME HD DBM trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
prime hd dbm

General Information


Serial Number87870713
Word MarkPRIME HD DBM
Filing DateTuesday, April 10, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 14, 2025
Registration Number5591954
Registration DateTuesday, October 23, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements


Description of MarkThe mark consists of the word "Prime" in which the dot of the "I" is two concentric circles. The letters "DBM" appear below the word "Prime". The letters "HD" appear to the right of the word "Prime", separated by a vertical line.
Goods and ServicesHuman allograft tissue
Pseudo MarkPRIME HUMAN DERMIS DEMINERALIZED BONE MATRIX
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"DBM"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 18, 2018
Primary Code005
First Use Anywhere DateWednesday, July 18, 2018
First Use In Commerce DateWednesday, July 18, 2018

Trademark Owner History


Party NameMusculoskeletal Transplant Foundation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Party NameMusculoskeletal Transplant Foundation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Party NameMusculoskeletal Transplant Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Trademark Events


Event DateEvent Description
Tuesday, May 8, 2018ASSIGNED TO EXAMINER
Friday, May 18, 2018ASSIGNED TO LIE
Friday, April 13, 2018NEW APPLICATION ENTERED
Wednesday, April 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 19, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 9, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 9, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, May 9, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 9, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, May 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Monday, September 17, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 21, 2018USE AMENDMENT FILED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 20, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 23, 2018REGISTERED-PRINCIPAL REGISTER
Monday, October 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords


prime tissue allograft human